Trial Profile
Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 29 Oct 2019 Status changed from active, no longer recruiting to completed.
- 15 Oct 2019 Planned End Date changed from 30 Sep 2019 to 19 Oct 2019.
- 15 Oct 2019 Planned primary completion date changed from 30 Sep 2019 to 19 Oct 2019.